Skip to main content

Education

  • Dr. Med at the Faculty of Medicine, University of Oslo (1996)
  • Specialist in rheumatology (2000)
  • Doctoral degree at the Faculty of Medicine, University of Oslo

Score

  • Section chief/Senior researcher at the Department of Rheumatology, Outpatient Clinic and Research, Diakonhjemmet Hospital
  • Professor II at the Department of Clinical Medicine, University of Oslo

Field of interest

  • Clinical rheumatology
  • Uric acid gout
  • Rheumatoid arthritis
  • Osteoarthritis
  • Rehabilitation

Other

  • Leader of work package 6 in REMEDY (Long-term follow-up)

Email

This email address is being protected from spambots. You need JavaScript enabled to view it.

Email

visiting address

Diakonhjemmet hospital
Forstanderboligen
Reidar Kobros vei 8
0370 Oslo

Postal address

Diakohjemmet hospital
PO Box 23 Vinderen
0319 Oslo

Projects

WP1 - Optimized medical interventions

ARCTIC

Remission in patients with rheumatoid arthritis: a randomized controlled trial investigating the use of ultrasound in clinical follow-up

Project Manager:
Espen A. Haavardsholm
WP6 - Dechiphering long-term outcomes

NOECON

Health economics in the treatment of inflammatory arthritis diseases

Project Manager:
Sell ​​Aarrestad Provan
WP6 - Dechiphering long-term outcomes

NOR Gout

Gout in Norway

Project Manager:
Till Uhlig
WP1 - Optimized medical interventions

NORTH STAR

The Nordic study of strategy tests and registries for rheumatic diseases

Project Manager:
Espen A. Haavardsholm
WP3 - Pain mechanisms and management

Rehab Benefit

Specialized rehabilitation at private rehabilitation institutions

Project Manager:
Rikke Helene Moe
WP6 - Dechiphering long-term outcomes

RehabNytte - work

Rehabilitation and work participation

Project Manager:
Till Uhlig
WP5 - Innovative approaches to remote care

ReMonit Gout

Digital home follow-up and management of gout

Project Manager:
Nina Østerås

Publications

Publications taken from the National Science Archive (NVA):

Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomized controlled, non-inferiority trial

Kaja Eriksrud Kjørholt, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad


The Lancet Rheumatology

2024

Urinary prostanoids are elevated by anti-TNF and anti-IL6 receptor disease-modifying antirheumatic drugs but are not predictive of response to treatment in early rheumatoid arthritis

Jianyang Liu, Helena Idborg, Marina Korotkova, Kristina Lend, Ronald van Vollenhoven, Jon Lampa


Arthritis Research & Therapy

2024

Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity

Karen Holten, Nina Paulshus Sundlisæter, Joseph Sexton, Lena Bugge Nordberg, Till Uhlig, Tore Kristian Aaserud Kvien


RMD Open

2024

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

Violetta Dubovyk, Georgios K. Vasileiadis, Tahzeeb Fatima, Yuan Zhang, Meliha Crnkic Kapetanovic, Alf Kastbom


RMD Open

2024

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial

Kristina Lend, Frieda A. Koopman, Jon Lampa, Gerrit Jansen, Merete L. Hetland, Till Uhlig


Arthritis & Rheumatology

2023

2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases

Emma Dures, Bayram Farisoğulları, Eduardo José Ferreira Santos, Anna Molto, Caroline Feldthusen, Claire Harris


Annals of the Rheumatic Diseases

2023

Work Ability in the Year after Rehabilitation—Results from the RehabNytte Cohort

Mari Nilsen Skinnes, Rikke Helene Moe, Thomas Johansen, Peter Solvoll Lyby, Kjersti Dahl, Idun Eid


Journal of Clinical Medicine

2023

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study

Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Aaserud Kvien, Espen A. Haavardsholm, Hilde Berner Hammer


RMD Open

2023

Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study

Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Sella Aarrestad Provan, Tore Kristian Aaserud Kvien, Espen A. Haavardsholm


Rheumatology

2023

Effect of tapered versus stable treatment with tumor necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial

Siri Lillegraven, Nina Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Åse Lexberg


Annals of the Rheumatic Diseases

2023

EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis

Ioannis Parodis, Charlotte Girard-Guyonvarc'h, Laurent Arnaud, Oliver Distler, Andrea Domján, Cornelia HM Van Den Ende


Annals of the Rheumatic Diseases

2023

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomized controlled NORD-STAR trial

Mikkel Østergaard, Ronald F Van Vollenhoven, Anna Rudin, Merete Lund Hetland, Marte Schrumpf, Dan C Nordström


Annals of the Rheumatic Diseases

2023

Beliefs about medicines in gout patients: results from the NOR-Gout 2-year study

Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Aaserud Kvien, Espen A. Haavardsholm, WJ Taylor


Scandinavian Journal of Rheumatology

2023

Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography Study

Leanne Chen, Gregory D. Gamble, Anne Horne, Jill Drake, Anthony J. Doyle, Till Uhlig


Arthritis care & research

2023

Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout

Nicholas A Sumpter, Riku Takei, Murray Cadzow, Ruth Topless, Amanda Phipps-Green, Rinki Murphy


Arthritis & Rheumatology

2022

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study

Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Kvien, Espen A. Haavardsholm, F. Perez-Ruiz


Clinical Rheumatology

2022

Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments

Geir Smedslund, Martina Kotar, Till Uhlig


Rheumatology International

2022

Sex differences in remission rates over 24 weeks among three different biological treatments compared to conventional therapy in patients with early rheumatoid arthritis (NORD-STAR): a post-hoc analysis of a randomized controlled trial

Kristina Lend, Ronald F van Vollenhoven, Jon Lampa, Merete Lund Hetland, Espen A. Haavardsholm, Dan Nordström


The Lancet Rheumatology

2022

Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study

Hilde Berner Hammer, Silvia Christin Hellerud Rollefstad, Anne Grete Semb, Gro Elisabeth Jensen, Lars Fridtjof Karoliussen, L Terslev


RMD Open

2022

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study

Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Kvien, Espen A. Haavardsholm, Fernando Perez-Ruiz


Arthritis Research & Therapy

2022

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study

Nina Beate Paulshus Sundlisæter, Ulf Gunnar Sundin, Anna-Birgitte Aga, Joseph Sexton, Hilde Berner Hammer, Till Uhlig


RMD Open

2022

Two-year reduction of dual-energy CT urate deposits during a treat-to-target strategy in gout in the NOR-Gout longitudinal study.

Till Uhlig, Tron Hovind Eskild, Lars Fridtjof Karoliussen, Joseph Sexton, Tore Kristian Kvien, Espen A. Haavardsholm


Rheumatology

2021

Blood chemokine levels are markers of disease activity but not predictors of remission in early rheumatoid arthritis

Jonathan Aldridge, Anna-Carin Lundell, Kerstin Andersson, Linda Mark, Merete Lund Hetland, Mikkel Østergaard


Clinical and Experimental Rheumatology

2021

Associations between Fluorescence Optical Imaging and Magnetic Resonance Imaging and symptoms in hand osteoarthritis.

Øystein Gunnar Maugesten, Sarah Ohrndorf, Barbara Therese Slatkovsky Christensen, Tore Kristian Kvien, Till Uhlig, Ida Kristin Bos-Haugen


Rheumatology

2021

Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.

Marit Stockfelt, Anna-Carin Lundell, Merete Lund Hetland, Mikkel Østergaard, Till Uhlig, Marte Schrumpf


Arthritis Research & Therapy

2021

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

Karen Holten, Nina Beate Paulshus Sundlisæter, Siri Lillegraven, Joseph Sexton, Lena Kristine Bugge Nordberg, Ellen Moholt


Annals of the Rheumatic Diseases

2021

Associations between joint pathologies and central sensitization in persons with hand osteoarthritis: Results from the Nor-Hand study

Pernille Steen Pettersen, Tuhina Neogi, Karin Magnusson, Alexander Mathiessen, Hilde Berner Hammer, Till Uhlig


Rheumatology

2021

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumor necrosis factor inhibitors: data from register linkage of the NOR-DMARD study

Ingrid Egeland Christensen, Siri Lillegraven, Mielnik Pawel, Gunnstein Bakland, Liz Paucar Loli, Joseph Sexton


Annals of the Rheumatic Diseases

2021

Flare rate thresholds for patient assessment of disease activity states in Gout

William J. Taylor, Nicola Dalbeth, Kenneth Saag, Jasvinder A. Singh, Elizabeth J. Rahn, Amy S. Mudano


Journal of Rheumatology

2021

Which factors predict discordance between a patient and physician on a gout flare?

Aprajita Jagpal, Elizabeth J. Rahn, Amy S. Mudano, Nicola Dalbeth, William J. Taylor, Kenneth G. Saag


Rheumatology

2021

12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: Achievements of the urate target levels and predictors of obtaining this target

Till Uhlig, Lars Fridtjof Karoliussen, Joseph Sexton, Tove Borgen, Espen A. Haavardsholm, Tore Kristian Kvien


RMD Open

2021

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients with Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial

Siri Lillegraven, Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Hallvard Fremstad


Journal of the American Medical Association (JAMA)

2021

Evaluation of three scoring methods for Fluorescence Optical Imaging in erosive hand osteoarthritis and rheumatoid arthritis

Øystein Gunnar Maugesten, S. Ohrndorf, D. Glinatsi, M. Ammitzbøll-Danielsen, Y. Kisten, M. Østergaard


Osteoarthritis and Cartilage Open

2020

Validity and diagnostic performance of fluorescence optical imaging measuring synovitis in hand osteoarthritis: baseline results from the Nor-Hand cohort

Øystein Gunnar Maugesten, Alexander Mathiessen, Hilde Berner Hammer, Sigrid Valen Hestetun, Tore Kristian Kvien, Till Uhlig


Arthritis Research & Therapy

2020

Active conventional treatment and three different biological treatments in early rheumatoid arthritis: Phase IV investigator initiated, randomised, observer blinded clinical trial

Merete Lund Hetland, Espen A. Haavardsholm, Anna Rudin, Dan C. Nordström, Michael Nurmohamed, Bjorn Gudbjornsson


The BMJ

2020

Conventional versus ultrasound treat to target: No difference in magnetic resonance imaging inflammation or joint damage over 2 years in early rheumatoid arthritis

Ulf Gunnar Sundin, Anna-Birgitte Aga, Øivind Skare, Lena Kristine Bugge Nordberg, Till Uhlig, Hilde Berner Hammer


Rheumatology

2020

Trajectories of fatigue in actively treated patients with established rheumatoid arthritis starting biologic DMARD therapy

Sella Aarrestad Provan, Brigitte Michelsen, Joseph Sexton, Till Uhlig, Hilde Berner Hammer


RMD Open

2020

EULAR/eumusc.net standards of care for rheumatoid arthritis: cross-sectional analyzes of importance, level of implementation and care gaps experienced by patients and rheumatologists across 35 European countries

Rachelle Meisters, Polina Putrik, Sofia Ramiro, Monika Hifinger, Andras P. Keszei, Yvonne van Eijk-Hustings


Annals of the Rheumatic Diseases

2020

Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study

Hilde Berner Hammer, Lars Fridtjof Karoliussen, Lene Terslev, Espen A Haavardsholm, Tore Kristian Kvien, Till Uhlig


Annals of the Rheumatic Diseases

2020

Fatigue is cross-sectionally not associated with objective assessments of inflammation, but changes in fatigue are associated with changes of disease activity assessments during biologic treatment of patients with established rheumatoid arthritis

Hilde Berner Hammer, Brigitte Michelsen, Joe Sexton, Till Uhlig, Sella Aarrestad Provan


Clinical Rheumatology

2020

Achievement of Remission in Two Early Rheumatoid Arthritis Cohorts Implementing Different Treat-to-Target Strategies

Vibeke Norvang, Gina Charlotte Hetland Brinkmann, Kazuki Yoshida, Siri Lillegraven, Anna-Birgitte Aga, Joseph Andrew Sexton


Arthritis & Rheumatology

2020

Associations Between Radiographic and Ultrasound‐Detected Features in Hand Osteoarthritis and Local Pressure Pain Thresholds

Pernille Steen Pettersen, Tuhina Neogi, Karin Magnusson, Hilde Berner Hammer, Till Uhlig, Tore Kristian Kvien


Arthritis & Rheumatology

2020

Gout, Hyperuricemia, and Crystal-Associated Disease Network consensus statement regarding labels and definitions for disease elements in gout

David Bursill, William J. Taylor, Robert Terkeltaub, Masanari Kuwabara, Tony R. Merriman, Rebecca Grainger


Arthritis care & research

2019

2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout

Pascal Richette, Michael Doherty, Eliseo Pascual, Victoria Barskova, Fabio Becce, Johann Castaneda


Annals of the Rheumatic Diseases

2019

Patients with rheumatoid arthritis facing sick leave or work disability meet varying regulations: a study among rheumatologists and patients from 44 European countries.

Polina Putrik, Sofia Ramiro, Francis Guillemin, Márta Péntek, Francisca Sivera, Tuulikki Sokka


Annals of the Rheumatic Diseases

2019

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

David Bursill, William J. Taylor, Robert Terkeltaub, Abhishek Abhishek, Alexander K. So, Ana Beatriz Vargas-Santos


Annals of the Rheumatic Diseases

2019

Trends in All-Cause and Cardiovascular Mortality in Patients With Incident Rheumatoid Arthritis: A 20-year Follow-Up Matched Case-Cohort Study

Sella Aarrestad Provan, Siri Lillegraven, Joseph Sexton, Kristin Angel, Cathrine Austad, Espen A. Haavardsholm


Rheumatology

2019

What Do We Measure With 28-joint DAS in Elderly Patients? An Exploratory Analysis in the NOR-DMARD Study

Marloes van Onna, Polina Putrik, Elisabeth Lie, Tore Kristian Kvien, Annelies Boonen, Till Uhlig


Rheumatology

2019

Swollen, but not tender joints, are independently associated with ultrasound synovitis: Results from a longitudinal observational study of patients with established rheumatoid arthritis

Hilde Berner Hammer, Brigitte Michelsen, Joseph Sexton, Ida Kristin Haugen, Sella Aarrestad Provan, Espen A. Haavardsholm


Annals of the Rheumatic Diseases

2019

Peripheral and Central Sensitization of Pain in Individuals With Hand Osteoarthritis and Associations With Self-Reported Pain Severity

Pernille Steen Pettersen, Tuhina Neogi, Karin Magnusson, Hilde Berner Hammer, Till Uhlig, Tore Kristian Kvien


Arthritis & Rheumatology

2019

Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register

Sella Aarrestad Provan, Cathrine Austad, Vera Halsaa, Hilde Berner Hammer, Tore Kristian Kvien, Till Uhlig


Clinical and Experimental Rheumatology

2019

Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

Lena Kristine Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Elisabeth Lie


RMD Open

2018

Tender joint count may not reflect inflammatory activity in established rheumatoid arthritis patients: results from a longitudinal study

Hilde Berner Hammer, Brigitte Michelsen, Sella Aarrestad Provan, Joseph Sexton, Jon Lampa, Till Uhlig


Arthritis care & research

2018

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study

Vibeke Norvang, Joseph Sexton, Eirik Kristianslund, Inge Christoffer Olsen, Till Uhlig, Gunnstein Bakland


RMD Open

2018

Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol

Nina Beate Paulshus Sundlisæter, Inge Christoffer Olsen, Anna-Birgitte Aga, Hilde Berner Hammer, Till Uhlig, Desirée van der Heijde


Rheumatology

2018

Burden of gout in the Nordic region, 1990–2015: findings from the Global Burden of Disease Study 2015

AA Kiadaliri, Till Uhlig, M. Englund


Scandinavian Journal of Rheumatology

2018

The impact of ultrasound on the use and efficacy of intraarticular glucocorticoid injections in early rheumatoid arthritis: Secondary analyzes from a randomized trial examining the benefit of ultrasound in a clinical tight control regimen

Lena Kristine Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, Joseph Sexton, Elisabeth Lie, Hilde Berner Hammer


Arthritis & Rheumatology

2018

Treating fatigue in rheumatoid arthritis: does patient age matter?

Till Uhlig, Sella Aarrestad Provan


Drugs & Aging

2018

Health‐related quality of life in women with endometriosis, compared with the general population and women with rheumatoid arthritis

Nina Julie Verket, Till Uhlig, Leiv Sandvik, Marit Helen Andersen, Tom Gunnar Tanbo, Erik Qvigstad


Acta Obstetricia et Gynecologica Scandinavica

2018

Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: Associations to future good radiographic and physical outcomes

Nina Beate Paulshus Sundlisæter, Anna-Birgitte Aga, Inge Christoffer Olsen, Hilde Berner Hammer, Till Uhlig, Desirée van der Heijde


Annals of the Rheumatic Diseases

2018

Health-related quality of life in patients with psoriatic and rheumatoid arthritis: Data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls

Brigitte Michelsen, Till Uhlig, Joseph Sexton, Desirée van der Heijde, Hilde Berner Hammer, Eirik Kristianslund


Annals of the Rheumatic Diseases

2018

The eumusc.net standards of care for rheumatoid arthritis: Importance and current implementation according to patients and healthcare providers in the Netherlands

Monika Hifinger, Sofia Ramiro, Polina Putrik, Yvonne van Eijk-Hustings, Anthony Woolf, Josef Sebastian Smolen


Clinical and Experimental Rheumatology

2018

Pain catastrophizing is strongly associated with subjective outcomes, but not with inflammatory assessments in rheumatoid arthritis patients.

Hilde Berner Hammer, Till Uhlig, Tore Kristian Kvien, Jon Lampa


Arthritis care & research

2018

Deriving common comorbidity indices from the MedDRA classification and exploring their performance on key outcomes in patients with rheumatoid arthritis

Polina Putrik, Sofia Ramiro, Elisabeth Lie, Kaleb Michaud, Maria Knoph Kvamme, Andras P. Keszei


Rheumatology

2018

Developing and testing a consensus-based core set of outcome measures for rehabilitation in musculoskeletal diseases

Mari Klokkerud, Hanne Dagfinrud, Till Uhlig, Turid Nygaard Dager, Kari Anita Furunes, Åse Klokkeide


Scandinavian Journal of Rheumatology

2018

Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons

Till Uhlig, Guro Løvik Goll


Rheumatology

2017

Head-to-head comparison of aggressive conventional therapy and three biological treatments and comparison of two de-escalation strategies in patients who respond to treatment: Study protocol for a multicenter, randomized, open-label, blinded-assessor, phase 4 study

Daniel Glinatsi, Marte Schrumpf, Anna Rudin, Dan C. Nordström, Espen A. Haavardsholm, Björn Gudbjörnsson


Trials

2017

Exercise for Hand Osteoarthritis: A Cochrane Systematic Review

Nina Østerås, Ingvild Kjeken, Geir Smedslund, Rikke Helene Moe, Barbara Therese Slatkovsky Christensen, Till Uhlig


Journal of Rheumatology

2017

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard

Alexis R. Ogdie, William J. Taylor, Tuhina Neogi, Jaap Fransen, Tim L. Jansen, H. Ralph Schumacher


Arthritis & Rheumatology

2017

Exercise for hand osteoarthritis

Nina Østerås, Ingvild Kjeken, Geir Smedslund, Rikke Helene Moe, Barbara Therese Slatkovsky Christensen, Till Uhlig


Cochrane Database of Systematic Reviews

2017

Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria

Lena Kristine Bugge Nordberg, Siri Lillegraven, Elisabeth Lie, Anna-Birgitte Aga, Inge Christoffer Olsen, Hilde Berner Hammer


Annals of the Rheumatic Diseases

2017

Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes

Cathrine Austad, Tore Kristian Kvien, Inge Christoffer Olsen, Till Uhlig


Scandinavian Journal of Rheumatology

2017

Calcium supplementation and inflammation increase mortality in rheumatoid arthritis: A 15-year cohort study in 609 patients from the Oslo Rheumatoid Arthritis Register

Sella Aarrestad Provan, Inge Christoffer Olsen, Cathrine Austad, Glenn Haugeberg, Tore Kristian Kvien, Till Uhlig


Seminars in Arthritis & Rheumatism

2017

Economic considerations and patients' preferences affect treatment selection for patients with rheumatoid arthritis: a discrete choice experiment among European rheumatologists

M. Hifinger, M. Hiligsmann, S Ramiro, V. Watson, JL Severens, B. Fautrel


Annals of the Rheumatic Diseases

2016

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard

Nicola Dalbeth, H. Ralph Schumacher, Jaap Fransen, Tuhina Neogi, Tim L. Jansen, Melanie Brown


Arthritis care & research

2016

2016 updated EULAR evidence-based recommendations for the management of gout

Pascal Richette, M. Doherty, E. Pascual, V. Barskova, F. Becce, J. Castañeda-Sanabria


Annals of the Rheumatic Diseases

2016

Less educated and older patients have reduced access to biologic DMARDs even in a country with highly developed social welfare (Norway): results from Norwegian cohort study NOR-DMARD

Polina Putrik, Sofia Ramiro, Elisabeth Lie, Andras P. Keszei, Tore Kristian Kvien, Desirée van der Heijde


Rheumatology

2016

Gout - new in diagnostics and treatment

Till Uhlig, Tron Hovind Eskild, Hilde Berner Hammer


Journal of the Norwegian Medical Association

2016

Ultrasound in the management of rheumatoid arthritis: ARCTIC randomized controlled strategy trial

Espen A. Haavardsholm, Anna-Birgitte Aga, Inge Christoffer Olsen, Siri Lillegraven, Hilde Berner Hammer, Till Uhlig


The BMJ

2016

Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach

Anna-Birgitte Aga, Hilde Berner Hammer, Inge Christoffer Olsen, Till Uhlig, Tore Kristian Kvien, Desirée van der Heijde


RMD Open

2016

Predictive value of arterial stiffness and subclinical carotid atherosclerosis for cardiovascular disease in patients with rheumatoid arthritis

Eirik Ikdahl, Silvia Christin Hellerud Rollefstad, Grunde Wibetoe, Inge Christoffer Olsen, Inger Jorid Berg, Jonny Hisdal


Journal of Rheumatology

2016

Achievement of remission and low disease activity definitions in patients with rheumatoid arthritis in clinical practice: Results from the Nor-Dmard study

Till Uhlig, Elisabeth Lie, Vibeke Norvang, Åse Lexberg, Erik Rødevand, Frode Krøll


Journal of Rheumatology

2016